Neurocrine Corp - NBIX Operatsion marja

Neurocrine Biosciences (NBIX) kompaniyasining korporativ logotipi

Ingrezza ning joriy muvaffaqiyati bozor tomonidan allaqachon hisobga olinganini hisobga olgan holda, Neurocrine Biosciences (NBIX) uchun o'sish kutiladimi? Javob operatsion marja darajasida yashiringan, u yerda 24.60 yangi mezonni belgilab, ushbu neyrobiologiya sohasidagi biofarmatsevtika innovatorining samaradorligini tasdiqlaydi. Kompaniyaning salohiyati keng ko'lamli R&D investitsiyalariga asoslangan, aksiyalarining kelgusidagi qiymati esa depressiya va shizofreniyani davolash uchun yangi molekulalarning muvaffaqiyatiga bog'liq.

NBIX: Neurocrine Biosciences, Inc. Operatsion faoliyat rentabelligi 04.07.2022 - 20.11.2026

NBIX (Neurocrine Biosciences): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- emitentning bozor qiymati haqida ma'lumotlar:
Kompaniyaning har tomonlama tahlili:Neurocrine Corp, NBIX
Neurocrine Corp asosiy tovari

Professional kapital Neurocrine Biosciences (NBIX) profilini blokbaster tijoratlashtirish samaradorligi va R&D investitsiyalarining aniqligi prizmasi orqali baholaydi. GURU.Markets platformasida operatsion foyda marjalarini tahlil qilib, investor tushumda asosiy operatsion foydaning ulushini kuzatadi, bu esa rahbariyatning nishtoviy biznesni kengaytirish qobiliyatini aks ettiradi va yuqori sifatli operatsion xarajatlar boshqaruvi tufayli aktivning fundamental ishonchliligini tasdiqlaydi.

Raqobatchilar tahlili

Sotuvning operatsion marjasi BIIB|Regencell Corp (RGC) - Operatsion faoliyat rentabelligi|Operatsion marja AXSM|Sotuvning operatsion marjasi ACADIA Pharmaceuticals ACAD|Operatsion marja XENE (Xenon Pharmaceuticals Inc.)|VKTX (Viking Therapeutics, Inc.) - Operatsion foyda marjasi|SUPN - Operatsion rentabellik|Catalyst Pharmaceuticals Inc (CPRX) - Sotuvning operatsion marjasi|DNLI (Denali Corp) - Sotuvning operatsion marjasi|Sotuvning operatsion rentabelligi harmonybiosciences.com (HRMY)|Sotuvning operatsion marjasi BHVN|Operatsion marja Amylyx|Operatsion marja TRVI|PRAX (Praxis Corp) - Operatsion foyda normasi|Operatsion marja AVXL (anavex.com)|CBLL: Operatsion foyda bo'yicha sotuv rentabelligi|PRTA - Operatsion rentabellik|ALEC - Operatsion marja|Annexon Inc. (ANNX) - Operatsion rentabellik|Sotuvning operatsion marjasi Omeros Corp|Sotuvning operatsion marjasi NGNE|ACIU: Operatsion foyda normasi|Sotuvning operatsion marjasi VYGR (Voyager Corp)|Sotuvning operatsion marjasi Neumora NMRA|Operatsion rentabellik Scilex Holding Company, Inc. SCLX|Operatsion foyda bo'yicha marjinallik Tevogen Bio Inc.|ACOG - Operatsion rentabellik|Operatsion foyda bo'yicha marjinallik Cognition Therapeutics (CGTX)|IKT (Inhibikase Therapeutics) - Sotuvning operatsion marjasi|Cassava Sciences Inc (SAVA) - Operatsion marja|Sotuvning operatsion marjasi ASRT|Operatsion marja coyatherapeutics.com|Operatsion marja VTGN|Ovid Therapeutics - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja ABOS (Acumen Pharmaceuticals, Inc)|CRVO - Sotuvning operatsion marjasi|ATHE - Operatsion rentabellik|Operatsion faoliyat rentabelligi clene.com CLNN|PEPG: Operatsion marja|Operatsion foyda bo'yicha sotuv rentabelligi JUNS|RLMD (Relmada Corp) - Operatsion marja|Annovis Bio Inc (ANVS) - Operatsion faoliyat rentabelligi|Operatsion rentabellik Grace Therapeutics, Inc. (GRCE)|AIFF (Firefly Neuro) - Operatsion foyda normasi|Operatsion rentabellik Klotho Neurosciences KLTO|NRSN: Operatsion foyda bo'yicha sotuv rentabelligi|RVPH: Sotuvning operatsion marjasi|MTVA: Operatsion rentabellik|NRXS (NeurAxis Inc) - Sotuvning operatsion marjasi|Sotuvning operatsion marjasi Helius Medical Technologies, Inc.|Operatsion rentabellik Passage Bio Inc.|Sotuvning operatsion rentabelligi bionomics.com.au NEUP|Operatsion marja NERV|Operatsion marja Athira Pharma Inc (ATHA)|Operatsion marja ADXN (Addex Therapeutics Ltd.)|ALZN: Operatsion foyda bo'yicha sotuv rentabelligi|CYCN - Operatsion rentabellik|Sotuvning operatsion rentabelligi Protagenic Therapeutics, Inc.|KTTA (pasitheaclinics.com) - Sotuvning operatsion marjasi|Operatsion foyda bo'yicha marjinallik Cortigent, Inc. CRGT|Operatsion rentabellik Avenue Therapeutics, Inc.|Sotuvning operatsion marjasi BrainStorm Cell Therapeutics Inc. (BCLI)|Operatsion rentabellik Cara Therapeutics, Inc (CARA)|Operatsion rentabellik CHRO (Chromocell Therapeutics Corp.)|Operatsion marja ELYM (eliemtx.com)|intracellulartherapies.com - Operatsion rentabellik|LBPH: Sotuvning operatsion marjasi|Operatsion foyda normasi MRNS (Marinus Pharma)|NKGN (nkgenbiotech.com) - Sotuvning operatsion marjasi|Sotuvning operatsion marjasi NeuroBo Pharmaceuticals|SAGE (Sage Therapeutics Inc.) - Operatsion marja|Neurotrope - Operatsion foyda marjasi|Operatsion marja TRVN|Operatsion faoliyat rentabelligi Vigil Neuroscience, Inc.|Operatsion rentabellik Anew Medical, Inc. WENA|CERE - Sotuvning operatsion marjasi